Pharmaceutical Technology on MSN
Pathos AI completes $237M Series E round to expand oncology pipeline
Pathos AI will use the proceeds to scale its Foundry platform and advance four active clinical cancer programmes.
Identify investment targets, pipeline priorities, partnerships, and sector entry strategies through high-level regulatory, clinical, sales, and market-based analysis.Dublin, Oct. 20, 2026 (GLOBE ...
Track Charcot-Marie-Tooth pipeline innovation, from first-in-class therapies to gene therapy, with clinical progress, unmet needs, collaborations, licensing and M&A insightsDublin, Oct. 22, 2026 ...
- License and development agreement with Janssen leverages Pipeline’s expertise in precision neuroregeneration and Janssen’s development experience across nervous system disorders SAN DIEGO--(BUSINESS ...
The world of Alzheimer's treatments is at an inflection point as more potential drugs make their way out of clinical trials. On the heels of newly FDA-approved drugs Aduhelm (aducanumab) in 2021 and ...
More than 6 million Americans are living with Alzheimer's disease, a staggering number that's expected to double within the next 30 years. But there are signs of optimism in the fight against ...
The Foreign, Commonwealth & Development Office released its only commercial pipeline for the year. The report included 121 opportunities, with an estimated total budget of £2.2 billion. We looked into ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results